IGHA1 and COVID-19: In these analyses, we found differences in isotype distribution, with a decrease of IgM in melanoma patients compared to HV, COVID and Tonsils, a decrease of IgA1 compared to EB and COVID-19 and an increase of IgG1 and IgG3 compared to HV and COVID (Fig. 6d).